Granules India Limited (GRANULES)-Financial and Strategic SWOT Analysis Review

Granules India Limited (GRANULES)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH82381FSA
  • |
  • Pages: 41
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Granules India Limited (GRANULES)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Granules India Limited (Granules) is a pharmaceutical manufacturing company, which carries out the research, development and manufacture of active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs) and finished dosages (FDs). The company manufactures Paracetomol, Ibuprofen, Metformin, Guaifenesin and Methocarbamol. It has premier facilities for the manufacture of APIs, PFIs and FDs. With sales offices in India, the US, the UK, China and Colombia, the company offers products and solutions to companies across the world. Granules has sales offices located in India, the US, the UK, China and Colombia. The company has three facilities in Hyderabad, India; one facility in Visakhapatnam, India; and one facility in Jingmen, China. Granules is headquartered in Hyderabad, Telangana, India.

Granules India Limited Key Recent Developments

Apr 28, 2016: Granules India : Revenue increases 11% to Rs. 1,431 Cr.; Net Profit surges 30% to Rs. 118 Cr

Jan 28, 2016: Granules India : Revenue increases 8% to Rs. 345 Cr.; Net Profit surges 15% to Rs. 27 Cr

Dec 21, 2015: Granules India's Two Facilities Located in Andhra Pradesh and Telangana Completed FDA Inspection

Oct 31, 2015: Granules India's Revenue increases 19% to Rs. 366 Cr.; Net Profit surges 40% to Rs. 31 Cr.

Jul 23, 2015: Granules India's Revenue increases 11% to Rs. 346 Cr.; Net Profit surges 19% to Rs. 27 Cr.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

Granules India Limited-Key Facts 6

Granules India Limited-Key Employees 7

Granules India Limited-Key Employee Biographies 8

Granules India Limited-Major Products and Services 9

Granules India Limited-History 10

Granules India Limited-Company Statement 11

Granules India Limited-Locations And Subsidiaries 12

Head Office 12

Other Locations & Subsidiaries 12

Joint Venture 12

Section 2-Company Analysis 13

Granules India Limited-Business Description 13

Granules India Limited-Corporate Strategy 14

Granules India Limited-SWOT Analysis 15

SWOT Analysis-Overview 15

Granules India Limited-Strengths 15

Strength-Leading Position 15

Strength-Focused Research & Development Activities 15

Strength-Increase in Products Sales 15

Granules India Limited-Weaknesses 16

Weakness-Declining Revenue: Latin America 16

Granules India Limited-Opportunities 17

Opportunity-Global Pharmaceutical Outsourcing Market 17

Opportunity-Expansion Initiatives 17

Opportunity-In-Licensing Agreement 17

Granules India Limited-Threats 18

Threat-Intense Competition 18

Threat-Stringent Government Regulations 18

Threat-Industry Consolidation 18

Granules India Limited-Key Competitors 19

Section 3-Company Financial Ratios 20

Financial Ratios-Capital Market Ratios 20

Financial Ratios-Annual Ratios 21

Performance Chart 23

Financial Performance 23

Financial Ratios-Interim Ratios 24

Financial Ratios-Ratio Charts 25

Section 4-Company's Lifesciences Financial Deals and Alliances 26

Granules India Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 26

Granules India Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 27

Granules India Limited, Recent Deals Summary 28

Section 5-Company's Recent Developments 29

Apr 28, 2016: Granules India : Revenue increases 11% to Rs. 1,431 Cr.; Net Profit surges 30% to Rs. 118 Cr 29

Jan 28, 2016: Granules India : Revenue increases 8% to Rs. 345 Cr.; Net Profit surges 15% to Rs. 27 Cr 30

Dec 21, 2015: Granules India's Two Facilities Located in Andhra Pradesh and Telangana Completed FDA Inspection 31

Oct 31, 2015: Granules India's Revenue increases 19% to Rs. 366 Cr.; Net Profit surges 40% to Rs. 31 Cr. 32

Jul 23, 2015: Granules India's Revenue increases 11% to Rs. 346 Cr.; Net Profit surges 19% to Rs. 27 Cr. 33

Apr 27, 2015: Granules India's FY15 Revenue increases 18% to Rs. 1,293 Cr.; Net Profit rises 21% to Rs. 91 Cr 34

Mar 16, 2015: FDA Inspects Granules India's Gagillapur Facility 35

Jan 28, 2015: Granules India's Revenue increases 13% to Rs. 320 Cr.; Net Profit rises 8% to Rs. 24 Cr. 36

Section 6-Appendix 37

Methodology 37

Ratio Definitions 37

About GlobalData 41

Contact Us 41

Disclaimer 41

List of Figures

Granules India Limited, Performance Chart (2012-2016) 23

Granules India Limited, Ratio Charts 25

Granules India Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 26

Granules India Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 27

List of Tables

Granules India Limited, Key Facts 6

Granules India Limited, Key Employees 7

Granules India Limited, Key Employee Biographies 8

Granules India Limited, Major Products and Services 9

Granules India Limited, History 10

Granules India Limited, Subsidiaries 12

Granules India Limited, Joint Venture 12

Granules India Limited, Key Competitors 19

Granules India Limited, Ratios based on current share price 20

Granules India Limited, Annual Ratios 21

Granules India Limited, Interim Ratios 24

Granules India Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 26

Granules India Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 27

Granules India Limited, Recent Deals Summary 28

Currency Codes 37

Capital Market Ratios 37

Equity Ratios 38

Profitability Ratios 38

Cost Ratios 39

Liquidity Ratios 39

Leverage Ratios 40

Efficiency Ratios 40

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Granules India Limited, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 300 INR 19482
Site License
USD 600 INR 38964
Corporate User License
USD 900 INR 58446

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com